Beijing Wandong Medical TechnologyLtd Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Beijing Wandong Medical TechnologyLtd.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 26.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
There's Reason For Concern Over Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Massive 28% Price Jump
Nov 12Returns On Capital At Beijing Wandong Medical TechnologyLtd (SHSE:600055) Paint A Concerning Picture
Oct 23Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Price Is Out Of Tune With Earnings
Sep 26Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Returns On Capital Not Reflecting Well On The Business
Jun 25We Think You Should Be Aware Of Some Concerning Factors In Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Earnings
May 03What Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) 26% Share Price Gain Is Not Telling You
Mar 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Beijing Wandong Medical TechnologyLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 1,404 | 184 | 143 | 187 | N/A |
6/30/2024 | 1,342 | 197 | 143 | 186 | N/A |
3/31/2024 | 1,290 | 191 | 148 | 177 | N/A |
12/31/2023 | 1,237 | 189 | 191 | 208 | N/A |
9/30/2023 | 1,314 | 192 | 143 | 159 | N/A |
6/30/2023 | 1,259 | 192 | 172 | 188 | N/A |
3/31/2023 | 1,166 | 181 | 150 | 166 | N/A |
12/31/2022 | 1,121 | 175 | 171 | 185 | N/A |
9/30/2022 | 1,088 | 166 | 88 | 107 | N/A |
6/30/2022 | 1,118 | 159 | 110 | 126 | N/A |
3/31/2022 | 1,127 | 159 | 94 | 105 | N/A |
12/31/2021 | 1,156 | 183 | 78 | 90 | N/A |
9/30/2021 | 1,196 | 193 | 357 | 373 | N/A |
6/30/2021 | 1,124 | 199 | 340 | 360 | N/A |
3/31/2021 | 1,122 | 219 | 345 | 366 | N/A |
12/31/2020 | 1,132 | 221 | 497 | 520 | N/A |
9/30/2020 | 1,082 | 226 | 367 | 413 | N/A |
6/30/2020 | 1,107 | 230 | 325 | 366 | N/A |
3/31/2020 | 1,071 | 214 | 283 | 328 | N/A |
12/31/2019 | 982 | 169 | 53 | 95 | N/A |
9/30/2019 | 972 | 156 | -2 | 40 | N/A |
6/30/2019 | 952 | 155 | 8 | 52 | N/A |
3/31/2019 | 982 | 155 | 35 | 73 | N/A |
12/31/2018 | 955 | 153 | 33 | 76 | N/A |
9/30/2018 | 968 | 134 | -98 | -40 | N/A |
6/30/2018 | 933 | 121 | N/A | -105 | N/A |
3/31/2018 | 898 | 110 | N/A | -139 | N/A |
12/31/2017 | 884 | 109 | N/A | -78 | N/A |
9/30/2017 | 785 | 90 | N/A | -20 | N/A |
6/30/2017 | 764 | 70 | N/A | 37 | N/A |
3/31/2017 | 808 | 83 | N/A | 97 | N/A |
12/31/2016 | 813 | 72 | N/A | 103 | N/A |
9/30/2016 | 860 | 60 | N/A | 63 | N/A |
6/30/2016 | 855 | 52 | N/A | 43 | N/A |
3/31/2016 | 832 | 51 | N/A | 44 | N/A |
12/31/2015 | 818 | 40 | N/A | -16 | N/A |
9/30/2015 | 819 | 37 | N/A | 22 | N/A |
6/30/2015 | 779 | 35 | N/A | 18 | N/A |
3/31/2015 | 766 | 21 | N/A | -1 | N/A |
12/31/2014 | 740 | 26 | N/A | 34 | N/A |
9/30/2014 | 718 | 39 | N/A | 52 | N/A |
6/30/2014 | 732 | 37 | N/A | 56 | N/A |
3/31/2014 | 726 | 27 | N/A | 31 | N/A |
12/31/2013 | 765 | 44 | N/A | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 600055's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 600055's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 600055's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 600055's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 600055's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 600055's Return on Equity is forecast to be high in 3 years time